Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance

Chavez, Alberto O., Molina-Carrion, Marjorie, Abdul-Ghani, Muhammad A., Folli, Franco, DeFronzo, Ralph A., Tripathy, Devjit·2009·Diabetes Care
DOI 10.2337/dc09-0684

Cited by (390)

Items 301–390 of 390

  1. Thymus Maintenance and Regeneration by Specific Molecular Factors
    Andrew R. Mendelsohn, James W. Larrick · 2016 · Rejuvenation Research
  2. The effects of SGLT2 inhibitors in patients with metabolic dysfunction-associated fatty liver disease; a narrative review
    Mihaela Simona Popoviciu, Lorena Păduraru, Mominur Rahman, Fatema Akter Supti, Roxana Adriana Stoica, Delia Reurean‐Pintilei, Cristina Ioana Bica, Simona Daniela Cavalu · 2024 · Journal of Mind and Medical Sciences
  3. Circulating fibroblast growth factor 21 is associated with blood pressure in the Chinese population: a community-based study
    Juanying Zhen, Shuyun Liu, Lin Liu, Xiaodan Zheng, Guoru Zhao, Jianguo Liang, Aimin Xu, Chao Li, Lijie Ren, Jun Wu et al. · 2025 · Annals of Medicine
  4. Association of circulating fibroblast growth factor 21 levels with all-cause and cardiovascular mortality: The multi-ethnic study of atherosclerosis
    William J. Tucker, Bradley Tucker, Andrzej S. Januszewski, Alicia Josephine Jenkins, ANTHONY C. KEECH, Bryan R. Kestenbaum, Matthew Allison, Kerry‐Anne Rye, Kwok Leung Ong · 2024 · Clinica Chimica Acta
  5. Plasma FGF21 Levels Are Not Associated with Weight Loss or Improvements in Metabolic Health Markers upon 12 Weeks of Energy Restriction: Secondary Analysis of an RCT
    Anouk Gijbels, Sophie Schutte, Diederik Esser, Charlotte C. J. R. Michielsen, Els Siebelink, Monica Mars, Marco Mensink, Lydia A. Afman · 2022 · Nutrients
  6. High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients
    Fei Han, Ling Yin, Xiaoping Yu, Renyan Xu, Mingxiang Tian, Xinnong Liu, Lu Zhou, Liang‐Hao Hu, Weijuan Gong, Weiming Xiao et al. · 2023 · PeerJ
  7. Fibroblast growth factor 21 (FGF-21) in obese children: no relationship to growth, IGF-1, and IGFBP-3
    Thomas Reinehr, Christian Ludwig Roth, Joachim Woelfle · 2016 · Hormone Molecular Biology and Clinical Investigation
  8. Serum Fibroblast Growth Factor 21 in Patients with and without Pterygia
    Ghalam-Hosein Yaghoobi, Saeed Shokoohi-Rad, Hamid Jafarzadeh, Elham Abodollahi · 2020 · Journal of Ophthalmic and Vision Research
  9. Fibroblast Growth Factor 21 in Patients with Acromegaly
    Jowita Halupczok-Żyła, Aleksandra Jawiarczyk-Przybyłowska, Marek Skrzypski, Mathias Z. Strowski, Marek Bolanowski · 2017 · Experimental and Clinical Endocrinology & Diabetes
  10. The role of the glucagon‐FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition
    Maria Moreno-Lopez, Isaline Louvet, Nathalie Delalleau, Ana Acosta-Montalvo, Julien Thévenet, Gianni Pasquetti, Valéry Gmyr, Julie A. Kerr-Conte, François N. Pattou, Caroline Bonner et al. · 2024 · Diabetes Obesity and Metabolism
  11. Plasma Levels of Fibroblast Growth Factor 21 and Adverse Kidney Outcomes
    Hee Byung Koh, Hyo Jeong Kim, Hyung Woo Kim, Tae Ik Chang, Jung Tak Park, Tae‐Hyun Yoo, Shin‐Wook Kang, Seung Hyeok Han · 2025 · Mayo Clinic Proceedings
  12. The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
    Lili You, Xiaosi Hong, Hongshi Wu, Diefei Liang, Feng Li, Dinghao Zheng, Xiuwei Zhang, Dan Liu, Qingyu Chen, Li Yan et al. · 2023 · BMC Endocrine Disorders
  13. Fibroblast Growth Factor 21 Predicts Type 2 Diabetes in Taiwanese
    Shih‐Li Su, Cheng‐Ling Kuo, Ching‐Shan Huang, Chin-Shan Liu · 2013 · Zānghuà yīxué
  14. Fibroblast growth factor 21 and its influence on metabolic processes in the human body
    Galina A. Proshchai, Наталья Владимировна Ворохобина, E. Yu. Zagarskikh, Парцерняк Сергей Александрович, Alexander S. Partsernyak · 2018 · Vestnik of Saint Petersburg University Medicine
  15. Circulating fibroblast growth factor 21 links hemodynamics with kidney function in middle-aged and older adults: A mediation analysis
    Masahiro Matsui, Keisei Kosaki, Makoto Kuro‐o, Chie Saito, Kunihiro Yamagata, Seiji Maeda · 2021 · Hypertension Research
  16. Activation of brown adipose tissue by a low-protein diet ameliorates hyperglycemia in a diabetic lipodystrophy mouse model
    Marcos David Munoz, Alexa Zamudio, Maximilian A. McCann, Victoria Gil, Pingwen Xu, Chong Wee Liew · 2023 · Scientific Reports
  17. Effects of metformin on fibroblast growth factor 21 in patients with type 2 diabetes mellitus: faraway but so close
    Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Majid Sakhi Jabir, Salim Albukhaty · 2023 · The Egyptian Journal of Internal Medicine
  18. Sitagliptin reduces FAP-activity and increases intact FGF21 levels in patients with newly detected glucose abnormalities
    Anne K.N. Pedersen, Camilla Hage, Niels Jessen, Linda Mellbin, Mette Bjerre · 2022 · Molecular and Cellular Endocrinology
  19. A Tryptophan Hydroxylase Inhibitor Decreases Hepatic FGF21 Expression and Circulating FGF21 in Mice Fed A High-Fat Diet
    Katsunori Nonogaki, Takao Kaji, Mari Murakami · 2018 · Neuropsychiatry
  20. Fibroblast growth factor-21 levels in metabolic syndrome: Another instrument in a widening tool belt?
    Oluremi N Ajala, Samia Mora · 2018 · Atherosclerosis
  21. Development of diabetes mellitus following hormone therapy in prostate cancer patients is associated with early progression to castration resistance
    Tomonori Hayashi, Tomoyoshi Miyamoto, Noriaki Nagai, Atsufumi Kawabata · 2021 · Scientific Reports
  22. Maternal organokines throughout pregnancy as predictors of neonatal anthropometric characteristics and adiposity
    Jorge Valencia‐Ortega, Victoria Galicia-Hernández, Andrea Castillo-Santos, Miranda Molerés-Orduña, Carla Arceo-Cerna, Otilia Perichart‐Perera, Ameyalli Mariana Rodríguez-Cano, Carolina Rodríguez-Hernández, Guadalupe Estrada‐Gutiérrez, Ignacio Camacho‐Arroyo et al. · 2024 · Frontiers in Endocrinology
  23. Possible role of gingival crevicular fluid levels of Chemerin and Fibroblast growth factor 21 as biomarkers of periodontal disease in diabetic and non-diabetic patients. A diagnostic accuracy study
    Eman Mohammad Amr, Rasha Mostafa, Olfat Gamil Shaker · 2019 · Advanced Dental Journal
  24. Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
    Fahim Ebrahimi, Sandrine Andrea Urwyler, Matthias Johannes Betz, Emanuel Christ, Philipp Schüetz, Beat Müeller, Marc Yves Donath, Mirjam Christ‐Crain · 2021 · Scientific Reports
  25. The stimulatory effects of glucagon on cortisol and GH secretion occur independently from FGF-21
    Ilyas Akkar, Züleyha Karaca, Serpil Taheri, Kürşad Ünlühızarcı, Ayşa Hacıoğlu, Fahrettin Keleştimur · 2021 · Endocrine
  26. Metabolic Stress Index Including Mitochondrial Biomarker for Noninvasive Diagnosis of Hepatic Steatosis
    Jae Seung Chang, Jhii-Hyun Ahn, Seong Hee Kang, Sang Baek Koh, Jang‐Young Kim, Soon Koo Baik, Ji Hye Huh, Samuel S. Lee, Moon Young Kim, Kyu‐Sang Park · 2022 · Frontiers in Endocrinology
  27. Fibroblast growth factor 21 as a candidate of a novel serum biomarker for mitochondrial diabetes
    Yuji Komorita, Akiyo Shiroozu, Hidetoshi Nakamura · 2023 · Journal of Diabetes Investigation
  28. Changes in metabolic hormones and trace elements in CSF in active smokers indicate oxidative damage to brain cells
    Peiwen Zheng, Fan Wang, Hui Li, Hanlu Chen, Meng-Tong Li, Haozheng Ma, Jue He, Li Chen, Yanlong Liu, Haiyun Xu · 2024 · Endocrine Connections
  29. Hepatic lipogenesis marked by GCKR ‐modulated triglycerides increases serum FGF21 in children/teens with obesity
    C Maffeis, Anita Morandi, Chiara Zusi, Francesca Olivieri, Elena Fornari, Paolo Cavarzere, Claudia Anita Piona, Massimiliano Corradi, Federica Emiliani, Alessandro Da Ros et al. · 2024 · Diabetes Obesity and Metabolism
  30. Pharmacologic inhibition of serotonin htr2b ameliorates hyperglycemia and the altered expression of hepatic FGF21, Sdf2l1, and htr2a in db/db mice and KKAy mice
    Katsunori Nonogaki, Takao Kaji · 2020 · Heliyon
  31. The FGF Family in Humans, Mice, and Zebrafish: Development, Physiology, and Pathophysiology
    Sayaka Sasaki, Hiroya Ohta, Yoshiaki Nakajima, Morichika Konishi, Ayumi Miyake, Nobuyuki Itoh · 2011 · InTech eBooks
  32. Fibroblast Growth Factor 21 is a Regulator of Energy Metabolism in the Liver and Adipose Tissue
    Niina Matikainen · 2014 · Elsevier eBooks
  33. Fibroblast growth factor-21 is a novel linkage between metabolic parameters, cardiovascular risk, and nephropathy in prediabetes
    RagaaA Matta, Sahar Hossam El-Hini, Mahmood Saad, Hanan Mostafa, Ahmed AbedelfadeeL · 2017 · Egyptian Journal of Obesity Diabetes and Endocrinology
  34. Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions
    Özge Besci, Merve Çelik Güler, Maria Cristina Foss‐Freitas, Elif A Oral · 2025 · Expert Review of Endocrinology & Metabolism
  35. Relationship Between Adipose Tissue and Liver Dysfunction in Women with Polycystic Ovary Syndrome and Metabolic Syndrome
    Sebastião Freitas de Medeiros, Gustavo Arantes Rosa Maciel · 2026 · Metabolites
  36. Histology of Cryopreserved Neonatal Rat Testes After Intratesticular Allotransplantation
    Bo Deng, V. A. Kireev, K.V. Melentyeva, Igor Kovalenko, Oleksandr V. Pakhomov · 2020 · Problems of Cryobiology and Cryomedicine
  37. Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue
    Niina Matikainen, Sanni Söderlund · 2019 · Elsevier eBooks
  38. FGF21 and its Relationship with Inflammatory and Metabolic Parameters in HIV Patients after Antiretroviral Treatment
    Alan Joel Ruiz-Padilla, Yeniley Ruíz‐Noa, Lorena del Rocío Ibarra‐Reynoso, María-Luisa Lazo-de-la-Vega-Monroy, Ángel Josabad Alonso‐Castro, Mauricio Sánchez-Barajas, Rosa Margarita Alvarez-Alvarez, Mónica del Carmen Preciado‐Puga · 2020 · Current HIV Research
  39. Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
    Liang-Te Chiu, Chi-Di Hung, Lin Lin, Yu‐Li Lin, Bang‐Gee Hsu · 2022 · International Journal of Hypertension
  40. Fibroblast growth factor 21: new insights from human studies
    Jakob Schiøler Hansen, Peter Plomgaard · 2016 · Cardiovascular Endocrinology
  41. Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers – A prospective cross‐over trial
    Johannes Pohlhammer, Matthias Wolfgang Heinzl, Carmen Klammer, Roland Feldbauer, Klemens Rosenberger, Michael Resl, Thomas Wagner, Florian Obendorf, Margot Egger-Salmhofer, Benjamin Dieplinger et al. · 2022 · Journal of Cellular and Molecular Medicine
  42. Letter to the Editor: Comment on “FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival” by Thiessen S.E., et al
    Peter Plomgaard, Cora Weigert · 2015 · The Journal of Clinical Endocrinology & Metabolism
  43. Endogenous GDF15 and FGF21 additively alleviate hepatic steatosis and insulin resistance in obese mice
    Satish Patel, Afreen Haider, Anna Álvarez-Guaita, Guillaume Bidault, Julia S. El-Sayed Moustafa, Esther Guiu‐Jurado, John A. Tadross, James Warner, James Harrison, Sam Virtue et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  44. A secondary analysis of indices of hepatic and beta cell function following 12 weeks of carbohydrate and energy restriction vs. free-living control in adults with type 2 diabetes
    Cody Garett Durrer, Hashim Islam, Haoning Howard Cen, María Dolores Moya-Garzón, Xuchao Lyu, Sean McKelvey, Joel Singer, Alan M. Batterham, Jonathan Z. Long, James D. Johnson et al. · 2024 · Nutrition & Metabolism
  45. Plasma FGF21 Concentration in Kidney Transplant Patients—Results from Prospective and Cross-Sectional Studies
    Magdalena Bartmańska, Andrzej Więcek, Marcin Adamczak · 2024 · Journal of Clinical Medicine
  46. Opposing impact of hypertension/diabetes following hormone therapy initiation and preexisting statins on castration resistant progression of nonmetastatic prostate cancer: a multicenter study
    Tomonori Hayashi, Tomoyoshi Miyamoto, Shiori Iwane, Masanori Fujitani, Kazuki Uchitani, Yuichi Koizumi, Atsushi Hirata, Hidefumi Kinoshita, Atsufumi Kawabata · 2024 · Scientific Reports
  47. Repeated Heat Stress Modulates the Levels of the Mitokines MOTS-C and FGF21 in Active Men during Calf Muscle Immobilization
    Rabie Elhusseiny, Mohammed Ihsan, Mariem Labidi, Marine Alhammoud, Khouloud Mtibaa, Nelda Nader, Nada Nasir, Abdulaziz Farooq, Emmanouil Papakostas, Bruno C. R. Olory et al. · 2025 · Medicine & Science in Sports & Exercise
  48. Insulin-like growth factor (IGF)-I, IGF-binding protein (IGFBP)-1, and fibroblast growth factor (FGF) 21 serum levels in Chinese women with and without gestational diabetes
    Donna Seto‐Young, Dimiter Bogdanov Avtanski, Kim So-Young, Vanessa Sy, Emilia Pauline Liao, Chaojie Liu, Stephen Wan, MARTIN L. LESSER, Leonid Poretsky · 2017 · Clinical Obstetrics Gynecology and Reproductive Medicine
  49. Circulating leukocyte cell-derived chemotaxin 2 and fibroblast growth factor 21 are negatively associated with cardiorespiratory fitness in healthy volunteers
    Sundus Malaikah, Scott A. Willis, Joseph J. Henson, Jack Alistair Sargeant, Thomas E. Yates, Alice Emily Thackray, Fernanda Reistenbach Goltz, Matthew J Roberts, Danielle Bernard-Deshong, Guruprasad Padur Aithal et al. · 2023 · Applied Physiology, Nutrition, and Metabolism
  50. Circulating serum fibroblast growth factor 21 as risk and prognostic biomarker of retinal artery occlusion
    Ruobing Shi, Hang Liu, Kaichao Xia, Ying Li, Ting Chen, Xuejie Li, Anhuai Yang, Xuan Xiao · 2024 · Scientific Reports
  51. Translation Reprogramming as a Novel Therapeutic Target in MAFLD
    Mayada Metwally, Thomas Berg, Emmanuel A. Tsochatzis, Mohammed Eslam · 2022 · Advanced Biology
  52. Investigation of the Proliferative Potential of FGF21 or FGF19 in Liver-Specific FGFR4-Deficient Mice
    Kerstin Wäse, Thomas Bartels, Uwe Schwahn, Mostafa Kabiri · 2023 · Toxicologic Pathology
  53. Long-term outcomes after pediatric liver transplantation
    Silja K. Kosola · 2013 · Työväentutkimus Vuosikirja
  54. Journée d’actualité en diabétologie 2009
    Marie Solignac · 2010 · Médecine des Maladies Métaboliques
  55. Association between Serum Fibroblast Growth Factor-21 Levels and Nonalcoholic Fatty Liver in Korean Men with Type 2 Diabetes
    Yong Jae Han, Ji Hye Huh, Jae Ho Seong, Jung Soo Lim, Mi Young Lee, Choon Hee Chung, Jang Yel Shin · 2015 · Korean Journal of Medicine
  56. CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
    Jody R. Dushay, Patricia C. Chui, Gosala S. Gopalakrishnan, Meghan B. Crawley, ffolliott Martin Fisher, Michael K. Badman · 2010
  57. Regulation of Metabolism by Hepatic OXPHOS: A Dissertation
    Thomas E. Akie · 2015 · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
  58. Fibroblast Growth Factor 21 is a Novel Protein Sensor in Pregnancy
    Elizabeth F. Sutton · 2017
  59. Role of Fsp27 in lípid homeostasis during nutrient deprivation
    Alexandra Carrilho do Rosario · 2018 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
  60. SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 21 AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH CORONARY ARTERY DISEASE WITH OBESITY
    K. Ivanova · 2018 · Bulletin of Problems Biology and Medicine
  61. Exercise habits and ageing health : exploring the associations of FGF21 and lung microbiome in glycaemic regulation, bone health, arterial stiffness and respiratory health
    Shuen Yee Lee · 2020
  62. LONG-TERM OUTCOMES AFTER Pediatric kliver transplantation
    Silja K. Kosola, Helena Isoniemi, Docent Matti Nuutinen · 2013
  63. Uninephrectomy and class II PI3K-C2β inactivation synergistically protect against obesity, insulin resistance and liver steatosis in mice
    Samira Alliouachene, Julius E. Kieswich, Benoît Bilanges, Kieran McCafferty, Christoph Thiemermann, Bart Vanhaesebroeck, Muhammad Yaqoob · 2020 · American Journal of Transplantation
  64. Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the FGF21 locus
    Ali Bayoumi · 2020 · The Sydney eScholarship Repository (The University of Sydney)
  65. Current literature in diabetes
    2010 · Diabetes/Metabolism Research and Reviews
  66. Serum FGF-21 levels in individuals with prediabetes and newly diagnosed type 2 diabetes mellitus
    Müjgan GÜRLER, İsmail Dağ, Naciye Özden Serin · 2022 · Experimental Biomedical Research
  67. THE EFFECTS OF EXENATIDE TREATMENT ON METABOLIC PARAMETERS, GHRELIN, GDF-15 AND FGF-21 IN OBESE TYPE 2 DIABETIC PATIENTS
    Müge Özsan Yılmaz, Oğuzhan Özcan · 2022 · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
  68. Peer Review #3 of "High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients (v0.1)"
    2023 · PeerJ
  69. Peer Review #1 of "High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients (v0.1)"
    2023 · PeerJ
  70. Peer Review #2 of "High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients (v0.1)"
    2023 · PeerJ
  71. Precision nutrition for cardiometabolic health: insights from human dietary intervention studies
    Anouk Gijbels · 2023
  72. FGF-21 and GDF-15 Levels in Patients with Insulin Resistance and It's Relation with Other Biochemical Parameters
    Serap Çetiner · 2023 · Eurasian Journal of Medical Investigation
  73. Cross-talk between hepatokines as Liver indused-exercise factors and organokines
    Reza Sabzevari Rad · 2023 · Research Square
  74. Signaling pathway and pharmacology
    Xiaokun Li · 2024 · Elsevier eBooks
  75. Effect of Eight-week Selected Aerobic and Resistance Exercises on the Plasma Levels of Irisin, Follistatin, and Fibroblast Growth Factor 21 in Women Recovered from COVID-19
    Parisa Amiri Farsani, Farshad Ghazalian, Sara Mobarak, Esmat Radmanesh, Mandana Gholami · 2023
  76. Assessment of retinol-binding protein-4, fibroblast growth factor-21, and dipeptidyl peptidase-4 in relation to obesity and insulin resistance of type 2 diabetes mellitus among Egyptian patients
    Ayat I. Ghanem, Atef Bassyouni, GhadaA Omar · 2021 · Journal of The Arab Society for Medical Research
  77. FGF21 reflects a responsive adipose tissue-liver axis in both cardiometabolic burden and following metabolic surgery
    Marie Patt, Isabel Karkossa, Laura Krieg, Lucas Massier, Kassem Makki, Shirin Tabei, Thomas Karlas, Arne Dietrich, Martin T. Gericke, Michael Stümvoll et al. · 2024 · medRxiv
  78. Effects of fibroblast growth factor 21 serum level on clinicopathological findings in papillary thyroid carcinoma.
    Seyedarad Mosalamiaghili, Hamideh Akbari, Narges Lashkarbolouk, Ali Ariannia, Mahshid Mehrjerdian, Fatemeh Salamat, Mahdi Mazandarani · 2025 · PubMed Central
  79. Therapeutic Potential of Sotagliflozin in Animal Models of Non-alcoholic Fatty Liver Disease with and without Diabetes
    Nitin Deshmukh, M. S. Kalshetti, Mohan Patil, Manohar Nandanwar, Ganesh V. Sangle · 2025 · Drug Research
  80. Effects of Asprosin and FGF21 on Weight Loss and Glucose Metabolism Following Sleeve Gastrectomy
    Alper Seydican Türker, Umut Rıza Gündüz, Güzin Aykal, Aydin Dincer, Hasan Özkan, Ömer Çelik, Muhammed Ali Aydın · 2025 · Indian Journal of Surgery
  81. Physical Exercise as a Therapeutic Approach for Patients Living with Type 2 Diabetes: Does the Explanation Reside in Exerkines?—A Review
    Daphné Bernard, Ariane Sultan, Karim Bouzakri · 2025 · International Journal of Molecular Sciences
  82. The value of fibroblast growth factor 21 in health and pathology
    Y. Akhverdyan, E. Papichev, B. V. Zavodovsky, Yu. V. Polyakova, L. E. Seewordova, Рожкова Екатерина Сергеевна · 2025 · Сибирский журнал клинической и экспериментальной медицины
  83. Additional file 1 of A secondary analysis of indices of hepatic and beta cell function following 12 weeks of carbohydrate and energy restriction vs. free-living control in adults with type 2 diabetes
    Cody Garett Durrer, Hashim Islam, Haoning Howard Cen, María Dolores Moya-Garzón, Xuchao Lyu, McKelvey, Sean, Singer, Joel, Alan M. Batterham, Jonathan Z. Long, Johnson, James D. et al. · 2024 · Figshare
  84. Association between gestational weight gain and metabolic and inflammatory biomarkers in the ETCHED cohort
    Sourav RoyChoudhury, Rachel Caballero, Dorota Wasak, Yunhua L. Muller, Zaqueena Coleman, William C. Knowler, Robert L. Hanson, Marilyn Q. Sale, Madhumita Sinha · 2026 · Scientific Reports
  85. Rôle des aminoacides ramifiés dans le déterminisme génétique de la résistance à l’insuline
    Sara Haydar · 2018 · theses.fr (ABES)
  86. Fonction de la signalisation de l'insuline dans le foie : impact sur la régulation de l'horloge circadienne et le dimorphisme sexuel de l'homéostasie glucidique
    Tiffany Fougeray · 2020 · theses.fr (ABES)
  87. Rôle des FGFs endocrines et leurs récepteurs au cours de la fibrose pulmonaire idiopathique
    Mada Ghanem · 2023 · theses.fr (ABES)
  88. Analysis of biochemical markers in noninvasive assessment of mitochondrial dysfunction and mitochondrial health
    Oksana M. Drapkina, Yu. S. Timofeev · 2026 · CARDIOVASCULAR THERAPY AND PREVENTION
  89. Perinatal Changes in Serum Fibroblast Growth Factor 21 and Their Association With Postpartum Insulin Resistance in Women With Gestational Diabetes Mellitus
    Yosuke Suzuki, Akihito Morita, Jun Okaniwa, Ayuko Tanaka, 祐子 長谷川, Tatsuya Sato, Daisuke Higeta, Akira Iwase · 2026 · Journal of obstetrics and gynaecology research
  90. Myokines and mitochondrial function in cardiometabolic diseases
    Jairo E. Saavedra, J. Gallo-Villegas, Juan C. Calderón · 2026 · Journal of physiology and biochemistry